Alliance Pharma PLC Director Shareholding (4889Q)

TIDMAPH

RNS Number : 4889Q

Alliance Pharma PLC

17 June 2015

 
 For immediate release   17 June 2015 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Director Shareholding

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was notified on 16 June 2015 that on 16 June 2015, Nigel Clifford, a Non-Executive Director of the Company, purchased 55,696 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 39.5pence per share, and his spouse, Jeanette Clifford, also purchased 58,227 Ordinary Shares on the same date at the same price.

Following this transaction, Mr Clifford's total beneficial interest in the Company is 113,923 Ordinary Shares, representing approximately 0.04% of the Company's issued share capital.

For further information:

 
 Alliance Pharma plc             + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 
 www.alliancepharma.co.uk 
                                     + 44 (0) 20 7466 
 Buchanan                                        5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                     + 44 (0) 20 7260 
 Numis Securities Limited                        1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: David 
  Poutney 
 

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSFRMFTMBBBBRA